Abstract:Li-Fraumeni syndrome is caused by inherited TP53 tumor suppressor gene mutations. MicroRNA miR-34a is a p53 target and modifier gene. Interestingly, miR-34 triple-null mice exhibit normal p53 responses and no overt cancer development, but the lack of miR-34 promotes tumorigenesis in cancer-susceptible backgrounds. miR-34 genes are highly conserved and syntenic between zebrafish and humans. Zebrafish miR-34a and miR-34b / c have similar expression timing in development, but miR-34a is more abundant. DNA damage by camptothecin led to p53-dependent induction of miR-34 genes, while miR-34a mutants were adult-viable and had normal DNA damage-induced apoptosis. Nevertheless, miR-34a -/- compound mutants with a gain-of-function tp53 R217H/ R217H or tp53-/- mutants were more cancer-prone than tp53 mutants alone, confirming the tumor-suppressive function of miR-34a . Through transcriptomic comparisons at 28 hours post-fertilization (hpf), we characterized DNA damage-induced transcription, and at 8, 28 and 72 hpf we determined potential miR-34a-regulated genes. At 72 hpf, loss of miR- 34a enhanced erythrocyte levels and up-regulated myb -positive hematopoietic stem cells. Overexpression of miR-34a suppressed its reporter mRNA, but not p53 target induction, and sensitized injected embryos to camptothecin but not to γ-irradiation. Li-Fraumeni syndrome, rooted in inherited mutations of the TP53 tumor suppressor gene, presents a complex interplay with microRNA34a ( miR-34a ), a known p53 target and modifier gene. Notably, miR-34 triple-null mice, despite exhibiting typical p53 responses and no evident cancer development, unveil a crucial role for miR-34 genes in suppressing tumorigenesis, particularly in predisposed conditions. The evolutionary conservation of miR-34 genes across zebrafish and humans underscores their significance. Studying zebrafish embryos reveals intriguing insights into miR-34a dynamics during development and its response to DNA damage, illuminating its involvement in cancer susceptibility. Additionally, experiments involving miR-34a mutants further confirm its tumor-suppressive function, especially when coupled with tp53 mutations. Transcriptomic analysis at different developmental stages uncover potential genes regulated by miR-34a, shedding light on its broader regulatory role. These findings enhance our understanding of the intricate mechanisms underlying cancer susceptibility and highlight miR-34a as a potential therapeutic target for Li-Fraumeni syndrome and related malignancies.

miR-34a is a tumor suppressor in zebrafish and its expression levels impact metabolism, hematopoiesis and DNA damage

Effect of Microrna-34a in Cell Cycle, Differentiation, and Apoptosis: A Review

Mir-196B Directly Targets Both HOXA9/MEIS1 Oncogenes and FAS Tumour Suppressor in MLL-rearranged Leukaemia.

tp53 R217H and R242H Mutant Zebrafish Exhibit Dysfunctional p53 Hallmarks and Recapitulate Li-Fraumeni Syndrome Phenotypes

Zebrafish Mir-462-731 Regulates Hematopoietic Specification and Pu.1-Dependent Primitive Myelopoiesis.

Knockout of miR-184 in zebrafish leads to ocular abnormalities by elevating p21 levels

MiR-144 regulates hematopoiesis and vascular development by targeting meis1 during zebrafish development.

Negative regulation of tumor suppressor p53 by microRNA miR-504.

microRNome analysis of the Zebrafish model of diamond-blackfan anemia from Rps19 deficiency

Mir-19b Promotes Tumor Growth and Metastasis Via Targeting Tp53

Knockdown and overexpression of miR-219 lead to embryonic defects in zebrafish development]

Lack of telomerase reduces cancer incidence and increases lifespan of zebrafish tp53M214K mutants

MicroRNA control of p53.

Abstract A53: Tumor suppressor microRNA miR‐34 inhibits human pancreatic and gastric cancer stem cells

Tissue-specific MicroRNA Expression Alters Cancer Susceptibility Conferred by a TP53 Noncoding Variant

MicroRNA Transcriptome Analysis Identifies Mir-365 As a Novel Negative Regulator of Cell Proliferation in Zmpste24 -Deficient Mouse Embryonic Fibroblasts

CRISPR/Cas9-mediated inactivation of miR-34a and miR-34b/c in HCT116 colorectal cancer cells: comprehensive characterization after exposure to 5-FU reveals EMT and autophagy as key processes regulated by miR-34

Zebrafish Microrna Mir-210-5p Inhibits Primitive Myelopoiesis by Silencing Foxj1b and Slc3a2a Mrnas Downstream of Gata4/5/6 Transcription Factor Genes

Abstract 2027: Proteomic analysis identifies pathways regulated by miR-34a

MicroRNA-34a: a Novel Tumor Suppressor in P53-Mutant Glioma Cell Line U251.

Csf1r mediates enhancement of intestinal tumorigenesis caused by inactivation of Mir34a